The offer for Allergan by William A. Ackman and Valeant Pharmaceuticals marks an unusual pairing of activist investor and corporate buyer that could reshape the deal landscape.
via NYT > Health http://ift.tt/1nnuJEz
via All Health and Fitness http://ift.tt/1jIh0ms
No comments:
Post a Comment